Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting

BACKGROUND: Magnetic resonance imaging (MRI) is the best biomarker of inflammatory disease activity in relapsing remitting Multiple Sclerosis (RRMS) so far but the association with disability is weak. Appearance of new MRI-lesions is used to evaluate response to immunotherapies in individual patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PeerJ
Autors principals: von Gumberz, Johanna, Mahmoudi, Mina, Young, Kim, Schippling, Sven, Martin, Roland, Heesen, Christoph, Siemonsen, Susanne, Stellmann, Jan-Patrick
Format: Artigo
Idioma:Inglês
Publicat: PeerJ Inc. 2016
Matèries:
Neurology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5036070/
https://ncbi.nlm.nih.gov/pubmed/27688965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.2442
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars